Establishment Labs Holdings Inc - Asset Resilience Ratio
Establishment Labs Holdings Inc (ESTA) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Establishment Labs Holdings Inc (ESTA) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (None–None)
This chart shows how Establishment Labs Holdings Inc's Asset Resilience Ratio has changed over time. See shareholders equity of Establishment Labs Holdings Inc for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Establishment Labs Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ESTA stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Establishment Labs Holdings Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Establishment Labs Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Establishment Labs Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
SHE:300760 |
Medical Devices | 0.64% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 50.79% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 6.89% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 33.68% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
LENSAR Inc
NASDAQ:LNSR |
Medical Devices | 13.15% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
Annual Asset Resilience Ratio for Establishment Labs Holdings Inc (None–None)
The table below shows the annual Asset Resilience Ratio data for Establishment Labs Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more